ATE506367T1 - Antivirale pyrimidinnukleosidderivate - Google Patents
Antivirale pyrimidinnukleosidderivateInfo
- Publication number
- ATE506367T1 ATE506367T1 AT07732706T AT07732706T ATE506367T1 AT E506367 T1 ATE506367 T1 AT E506367T1 AT 07732706 T AT07732706 T AT 07732706T AT 07732706 T AT07732706 T AT 07732706T AT E506367 T1 ATE506367 T1 AT E506367T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- pyrimidine nucleoside
- nucleoside derivatives
- neutral
- amino acid
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 150000003833 nucleoside derivatives Chemical class 0.000 title 1
- 239000002718 pyrimidine nucleoside Substances 0.000 title 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 2
- 150000001413 amino acids Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000007935 neutral effect Effects 0.000 abstract 2
- 239000004474 valine Substances 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 201000006082 Chickenpox Diseases 0.000 abstract 1
- 208000007514 Herpes zoster Diseases 0.000 abstract 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical group C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical group CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical group CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Chemical group CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 206010046980 Varicella Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 235000004279 alanine Nutrition 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229960000310 isoleucine Drugs 0.000 abstract 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Chemical group CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 abstract 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0609178.9A GB0609178D0 (en) | 2006-05-09 | 2006-05-09 | Novel compounds |
| PCT/GB2007/001677 WO2007129083A1 (en) | 2006-05-09 | 2007-05-09 | Anti-viral pyrimidine nucleoside derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE506367T1 true ATE506367T1 (de) | 2011-05-15 |
Family
ID=36637171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07732706T ATE506367T1 (de) | 2006-05-09 | 2007-05-09 | Antivirale pyrimidinnukleosidderivate |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US8329664B2 (enExample) |
| EP (1) | EP2016081B1 (enExample) |
| JP (1) | JP5261374B2 (enExample) |
| KR (1) | KR101447522B1 (enExample) |
| CN (1) | CN101443332B (enExample) |
| AT (1) | ATE506367T1 (enExample) |
| AU (1) | AU2007246814B2 (enExample) |
| BR (1) | BRPI0711354A2 (enExample) |
| CA (1) | CA2656780C (enExample) |
| CY (1) | CY1111711T1 (enExample) |
| DE (1) | DE602007014030D1 (enExample) |
| DK (1) | DK2016081T3 (enExample) |
| EA (1) | EA015178B1 (enExample) |
| ES (1) | ES2365057T3 (enExample) |
| GB (1) | GB0609178D0 (enExample) |
| IL (1) | IL194806A (enExample) |
| NZ (1) | NZ573377A (enExample) |
| PL (1) | PL2016081T3 (enExample) |
| PT (1) | PT2016081E (enExample) |
| SI (1) | SI2016081T1 (enExample) |
| TW (1) | TWI385172B (enExample) |
| WO (1) | WO2007129083A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0009486D0 (en) * | 2000-04-17 | 2000-06-07 | Univ Cardiff | Chemical compounds |
| GB2452556A (en) * | 2007-09-07 | 2009-03-11 | Univ Leuven Kath | Nucleoside analogues esterified at 3 and/or 5 positions by neutral non-polar amino acid, or oligopeptide thereof, for combating Varicella Zoster virus |
| JP2013539760A (ja) * | 2010-10-09 | 2013-10-28 | シナジー ファーマシューティカルズ インコーポレイテッド | 抗ウイルス化合物およびその有用な中間体の調製方法 |
| CN102443032B (zh) * | 2010-10-09 | 2015-07-22 | 英希比泰克斯公司 | 制备抗病毒组合物的方法及其中间体的应用 |
| MD4110C1 (ro) * | 2010-10-21 | 2011-12-31 | Валериу РУДИК | Preparat antiherpetiс |
| KR101875997B1 (ko) * | 2015-05-04 | 2018-07-06 | 엔 앤드 엔 파마세우티칼스 인크. | 엔-메탄노카르바티미딘을 이용한 대상포진의 치료방법 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62255499A (ja) | 1986-04-28 | 1987-11-07 | Teijin Ltd | 螢光性ヌクレオシド又はヌクレオチド |
| EP0346108A3 (en) | 1988-06-09 | 1991-04-24 | The Wellcome Foundation Limited | Anti-infective nucleosides |
| YU43193A (sh) | 1992-06-22 | 1997-01-08 | Eli Lilly And Company | 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi |
| GB9505025D0 (en) | 1995-03-13 | 1995-05-03 | Medical Res Council | Chemical compounds |
| US6022876A (en) * | 1996-11-15 | 2000-02-08 | Yale University | L-β-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections |
| GB9708611D0 (en) | 1997-04-28 | 1997-06-18 | Univ Cardiff | Chemical compounds |
| GB9716231D0 (en) | 1997-07-31 | 1997-10-08 | Amersham Int Ltd | Base analogues |
| HK1053126A1 (zh) | 1999-07-22 | 2003-10-10 | 新生物生物公司 | 酶催化的治疗活化 |
| IL147749A0 (en) | 1999-07-22 | 2002-08-14 | Newbiotics Inc | Methods for treating therapy-resistant tumors |
| JP2003527317A (ja) | 1999-07-22 | 2003-09-16 | ニューバイオティックス インコーポレイテッド | 酵素触媒抗感染性治療剤 |
| GB0009486D0 (en) | 2000-04-17 | 2000-06-07 | Univ Cardiff | Chemical compounds |
| GB0011203D0 (en) * | 2000-05-09 | 2000-06-28 | Univ Cardiff | Chemical compounds |
| MY141594A (en) * | 2000-06-15 | 2010-05-14 | Novirio Pharmaceuticals Ltd | 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES |
| US6875751B2 (en) * | 2000-06-15 | 2005-04-05 | Idenix Pharmaceuticals, Inc. | 3′-prodrugs of 2′-deoxy-β-L-nucleosides |
| AU2003247084B9 (en) * | 2002-06-28 | 2018-07-26 | Centre National De La Recherche Scientifique | Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections |
| US7582748B2 (en) * | 2003-03-20 | 2009-09-01 | Microbiologica Quimica E Farmaceutical Ltd. | Methods of manufacture of 2′-deoxy-β-L-nucleosides |
| US20050137141A1 (en) | 2003-10-24 | 2005-06-23 | John Hilfinger | Prodrug composition |
| AU2004320625B2 (en) | 2004-06-07 | 2009-08-27 | Anadys Pharmaceuticals, Inc. | 3-beta-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof |
-
2006
- 2006-05-09 GB GBGB0609178.9A patent/GB0609178D0/en not_active Ceased
-
2007
- 2007-05-09 BR BRPI0711354-4A patent/BRPI0711354A2/pt not_active IP Right Cessation
- 2007-05-09 CN CN2007800169982A patent/CN101443332B/zh not_active Expired - Fee Related
- 2007-05-09 ES ES07732706T patent/ES2365057T3/es active Active
- 2007-05-09 DK DK07732706.2T patent/DK2016081T3/da active
- 2007-05-09 JP JP2009508479A patent/JP5261374B2/ja not_active Expired - Fee Related
- 2007-05-09 PL PL07732706T patent/PL2016081T3/pl unknown
- 2007-05-09 AT AT07732706T patent/ATE506367T1/de active
- 2007-05-09 WO PCT/GB2007/001677 patent/WO2007129083A1/en not_active Ceased
- 2007-05-09 KR KR1020087029280A patent/KR101447522B1/ko not_active Expired - Fee Related
- 2007-05-09 NZ NZ573377A patent/NZ573377A/en not_active IP Right Cessation
- 2007-05-09 PT PT07732706T patent/PT2016081E/pt unknown
- 2007-05-09 SI SI200730661T patent/SI2016081T1/sl unknown
- 2007-05-09 AU AU2007246814A patent/AU2007246814B2/en not_active Ceased
- 2007-05-09 US US12/226,044 patent/US8329664B2/en not_active Expired - Fee Related
- 2007-05-09 EA EA200870505A patent/EA015178B1/ru not_active IP Right Cessation
- 2007-05-09 CA CA 2656780 patent/CA2656780C/en not_active Expired - Fee Related
- 2007-05-09 TW TW096116477A patent/TWI385172B/zh not_active IP Right Cessation
- 2007-05-09 EP EP07732706A patent/EP2016081B1/en not_active Not-in-force
- 2007-05-09 DE DE602007014030T patent/DE602007014030D1/de active Active
-
2008
- 2008-10-22 IL IL194806A patent/IL194806A/en active IP Right Grant
-
2011
- 2011-07-15 CY CY20111100693T patent/CY1111711T1/el unknown
-
2012
- 2012-11-30 US US13/690,794 patent/US8859512B2/en not_active Expired - Fee Related
-
2014
- 2014-09-10 US US14/482,125 patent/US9427447B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111711T1 (el) | Αντι-ιικα πυριμιδινικα νουκλεοζιτικα παραγωγα | |
| NO2018033I1 (no) | Varicella Zoster Virus (VZV) glykoproteinE (gE) - krav 1 i NO 341841 | |
| JO3067B1 (ar) | بيرميدينات بيرازولو امينو كمثبطات ل fak | |
| NZ597544A (en) | Modified 4'-nucleosides as antiviral agents | |
| EA201070164A1 (ru) | Твердый препарат, включающий алоглиптин и гидрохлорид метформина | |
| TW200738716A (en) | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative | |
| EA201170456A1 (ru) | Синергические комбинации макроциклического ингибитора вируса гепатита с и нуклеозида | |
| EA201591390A1 (ru) | Пиразол[1,5-a]пиримидины для противовирусного лечения | |
| MY145856A (en) | Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus | |
| NO20081581L (no) | Polymorfer av benzoatsalt av 2-[[6-[(3R)-3-amino-l-piperldinyl]-3,4-dihydro-3-metyl-2,4-diokso- 1(2H)-pyrlmidinylJmetyl)benzonitril, og fremgangsmater for anvendelse derav | |
| MY139243A (en) | Prodrugs of piperazine and substituted piperidine antiviral agents. | |
| WO2007029029A3 (en) | Tetracyclic indole derivatives as antiviral agents | |
| EA200801287A1 (ru) | Пиримидиновые производные для лечения аномального клеточного роста | |
| DE602007001463D1 (de) | Pyrimidin-, chinazolin-, pteridin- und triazinderivate | |
| EA200970041A1 (ru) | Ингибиторы акт (протеинкиназы в) | |
| MX2007013624A (es) | Inhibidores de proteina cinasa. | |
| PE20061378A1 (es) | INHIBIDORES DE LA ACTIVIDAD DE Akt | |
| SI2850054T1 (en) | A process for the production of amino acid compounds | |
| TW200500369A (en) | Cephem compounds | |
| JP2009536188A5 (enExample) | ||
| EA200702637A1 (ru) | Производные пурина | |
| GB0717526D0 (en) | Improvements in or relating to compositions for the treatment or prophylaxis of viral infections | |
| DE60011637D1 (de) | Dioxolan nukleosidanalogen zur behandlung und vorbeugung von viralen infektionen | |
| ECSP088170A (es) | Derivados de 5-piridinil-1-azabiciclo[3.2.1]octano, su preparación y su aplicación en terapéutica | |
| AR073699A1 (es) | 2-[1h-bencimidazol-2(3h)-iliden]-2-(pirimidin-2-il) acetamidas y 2-[benzotiazol-2(3h)-iliden]-2-(pirimidin-2-il) acetamidas inhibidores de quinasas, composiciones farmaceuticas que las contienen y su uso en el tratamiento del cancer. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2016081 Country of ref document: EP |